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Abstract 
 
 MyoD and Myf5 are transcription factors that regulate myogenesis by promoting 
satellite cell transcription. The two genes are known to display functional redundancy.  
Both genes are considered myogenic determination genes and are expressed in satellite 
cells. When one gene is inactive, the other is able to compensate for it and carry out 
normal myogenic programming. Myf5 is the first myogenic regulatory factor (MRF) to be 
expressed during myogenesis, followed by MyoD. The fate of myogenic precursors in the 
absence of both MyoD and Myf5 remains largely unknown. We aimed to begin attaining 
this knowledge as part of this project. We utilized a CreLoxP system to control the 
expression of MyoD in mice lacking Myf5. MyoD was knocked out at embryonic day (E) 
11.5 during myogenesis. Limbs were collected from experimental mice 2 days following 
tamoxifen injection. Additionally, recombined MyoD-/-Myf5-/- myogenic progenitor cells 
were plated and grown individually in culture for 13 days. Immunofluorescence staining 
was performed on whole tissue samples and cell culture samples to analyze potential fate 
changes. No signal that may indicate a fate change was detected in the limbs of 
experimental mice collected 2 days following the excision of MyoD. Cell culture data 
demonstrated the presence of signal that may indicate a potential fate change. However, 
making concrete conclusions from this data proved difficult due to the lack of positive 
controls available. 
 The second component of our project involved analyzing the function of MyoD in 
the regeneration of injured muscle. The CreLoxP system was utilized to excise MyoD 
from experimental mice containing a single allele of Myf5. Once again, MyoD was 
knocked out at E 11.5. Seven weeks following birth, mice limbs were injured and tissue 
samples were collected. Immunohistochemistry was utilized to analyze potential fate 
changes. Our data did not appear to demonstrate increase in signal that marks a fate 
switch, but is difficult to interpret with certainty without further studies.  
Introduction 
 
Skeletal myogenesis, the development of skeletal muscle tissue, takes place in 
three stages and results in the formation of muscle fibers, as well as muscle stem cells, or 
satellite cells. At each stage, myogenesis accomplishes a different functional goal. In 
embryonic myogenesis, dermomyotomal cells begin to develop, the limb bud is formed, 
and myoblasts start to arise. Later on in embryonic development, these cells proliferate 
and then fuse to form myotubes and, ultimately, muscle fibers. This stage of development 
begins at E 9.5. At E 10.5, MyoD is first expressed. Shortly afterwards, at E 11.5, 
myogenic progenitors are identified. During fetal myogenesis, which occurs from E 14.5 
until birth, the basic muscle scaffolding is established and its growth and development 
occurs8. Normal embryonic and fetal myogenesis leads to functional muscle, comprised 
of fibers and satellite cells.  
  Satellite cells function in postnatal myogenesis, particularly during the repair of 
damaged muscle8. These cells are first anatomically identified at E 16.5 and promote 
regeneration upon injury in adult myogenesis7. Found on the periphery of muscle fibers, 
satellite cells come into contact with the basal lamina, which is an extracellular matrix 
closely associated with the epithelium. A primary characteristic of adult stem cells is the 
ability to self-renew damaged tissue, which satellite cells have been shown to do. Upon 
injury, satellite cells demonstrate self-renewal and maintain homeostasis by repopulating 
muscle fibers as they proliferate. Because satellite cells divide asymmetrically, the result 
of this division is one cell that will be differentiated towards a myogenic fate and one 
new stem cell7.  
Another important quality of satellite cells is that they express Pax genes, which 
are critical in myogenesis6. This set of genes, specifically Pax3 and Pax7, regulate the 
entry of the satellite cells into the pathway of skeletal muscle differentiation2. Muscle 
fiber progenitors do not pass through the myogenic program without Pax3 and Pax7 and 
critical problems in the formation of skeletal muscle occur in animals that lack these 
genes2. Thus, Pax3 and Pax7 are vital for progression of adult satellite cells through the 
muscle development process.  
When Pax3 and Pax7 promote the activity of adult satellite cells in myogenesis, 
these cells up-regulate the expression of myogenic regulatory factors (MRFs), Myf5, 
MyoD, Mrf4, and Myogenin1. The four MRFs are also active prior to adult myogenesis. 
These basic helix-loop-helix (bHLH) transcription factors are present and operate in 
different stages of development to contribute to muscle fiber formation.. The 
determination of cells towards the myogenic fate is governed largely by the activity of 
Myf5 and MyoD, and in part by that of Mrf4. Myogenin is required for terminal skeletal 
muscle differentiation2. Mrf4 is believed to act as a muscle determination gene in the 
embryonic stage of development. Although each MRF has a distinct role, there is 
functional redundancy among some of the genes in control of myogenic development10 
 Myf5 is the first MRF to be expressed during embryonic myogenesis, acting as a 
transcription factor for genes that regulate myogenesis1. MyoD, expressed shortly after 
Myf5, is also a transcription factor. The gene binds to enhancer sequences of muscle-
specific genes to up-regulate their activity13. Although they are expressed at slightly 
different time points, MyoD and Myf5 are both considered myogenic determination 
genes, as each gene has been shown to initiate the myogenic program on its own. MyoD 
and Myf5 are able to activate muscle genes in multiple differentiated cell lines, 
demonstrating their sufficiency for the downstream program of terminal muscle fiber 
differentiation13. Thus, although neither gene alone is necessary for myogenesis, they are 
both sufficient. Additionally, both genes are responsible for regulating satellite cell gene 
transcription In the case of muscle tissue damage, MyoD is upregulated in order to 
promote the formation of new muscle fibers through satellite cell activation. As in 
myogenesis, Myf5 has a similar function to that of MyoD in regeneration. Thus, MyoD 
and Myf5 play significant, but overlapping, roles in determination and differentiation, as 
well as regeneration of myogenic cells	 
 
Figure 1. The roles of MyoD and Myf5 during myogenesis. Adapted from Salvatore et al., 2014. 
In 1992, Rudnicki et al. created a mouse model with a mutant knocked-out 
version of the MyoD gene. Surprisingly, the researchers found that the mice lacking 
MyoD were both viable and fertile. These mice showed normal levels of skeletal muscle-
specific mRNAs and elevated levels of Myf5 mRNA. Moreover, subsequent studies 
demonstrated that although limb myogenesis was somewhat delayed, these mutant adult 
mice appeared to have physiologically and morphologically normal muscle12. This data 
suggests that the activity of Myf5 can compensate for the loss of MyoD9. The following 
year, researchers created a mouse model with both Myf5 and MyoD knockouts. Because 
these mice completely lacked skeletal muscle and died perinatally, it was concluded that 
either MyoD or Myf5 is essential for formation of muscle fibers10. The fate of satellite 
cells in the double knockout mice is still undiscovered, and exploring how satellite cell 
progenitors develop in mice lacking Myf5 and MyoD was the goal of my research. 
Previous work in the Goldhamer lab has shown that when both MyoD and Myf5 are 
absent, satellite cell progenitors acquire different fates and thus we anticipated observing 
fate changes in this population of cells.		
Figure 2. Normal skeletal muscle anatomy. Adapted from Davis, et al. 2013. 
When myogenesis is complete, functional skeletal muscle is formed, as presented 
in Figure 2. Multinucleated fibers are organized upon an extracellular matrix (ECM) that 
is comprised of three layers: the epimysium (outermost layer), the perimysium 
(intermediate layer) and the endomysium (innermost layer)7. When severe injuries occur, 
as during a disease or trauma state, muscle fibers atrophy and scar tissue accumulates 
throughout the ECM. An increase in scar tissue promotes a rupture in this organization of 
skeletal muscle, thereby perpetuating disease states.   
 
Figure 3. Muscle regeneration following injury. Adapted from Dueweke, et al. 2016. 
At the cellular level, injury causes nuclei at the damaged site to undergo 
apoptosis, as shown in Figure 3. To repair muscle, satellite cells become activated, 
migrate to the injured location of the muscle, and proliferate to repopulate lost cells6.  At 
this stage, both MyoD and Myf5 contribute to the influx of new myogenic progenitor 
cells. These satellite cells then differentiate into myoblasts, fuse to form myotubes, and 
ultimately become functional muscle fibers2. Following muscle regeneration, some 
satellite cells return to a quiescent state in order to respond to subsequent injuries. The 
second component of this project involved analyzing if and how muscle is able to 
regenerate in the absence of MyoD. Because Myf5 and MyoD display functional 
redundancy, we hypothesized that regeneration would continue to occur. 
To analyze the capacity of muscle to develop in the absence of Myf5 and MyoD, a 
conditional knockout mouse model, which contains one conditional MyoD allele and is 
homozygous null for Myf5, was utilized. We utilized the CreLoxP system to knock out 
expression of MyoD at E 11.5, creating double-knockout experimental mice. The Cre 
protein enabled the recombination of the MyoD allele with the R26NG allele, which 
contains green fluorescent protein (GFP). As such, recombined alleles that lack MyoD 
were marked with GFP. However, recombination efficiency is not perfect and this can 
result in recombined cells that do contain the MyoD allele. Fusing the Cre protein to an 
estrogen receptor (ER) enabled us to control the function of the protein, and thus the 
expression of MyoD, with tamoxifen, a drug that mimics estrogen. In sum, when 
tamoxifen binds the Cre protein, the protein is able to enter the nucleus and subsequently 
excise MyoD. Therefore, the administration of tamoxifen done via intraperitoneal (IP) 
injection renders MyoD inactive in target cells.  
In order to assess the roles of MyoD and Myf5 in regeneration upon injury, we 
utilized the CreLoxP system coupled with tamoxifen injections to excise MyoD from 
mice that contained a functional allele of Myf5. In this way, we were able to knock out 
MyoD and examine if and how regeneration is able to occur solely through the effects of 
Myf5. 
As part of my Honors Scholar Thesis, I have worked in Dr. David Goldhamer’s 
lab to characterize the development of myogenic precursors that lack MyoD and Myf5.  
We first analyzed the development of these cells in the absence of MyoD and Myf5 within 
the limbs. Subsequently, we plated cells of interest and grew them for 13 days, after 
which we analyzed potential fate changes through immunohistochemistry. Lastly, we 
explored the role of these genes in regeneration by knocking MyoD out of Myf5+ 
experimental mice. Following injury, injured myogenic cells in mice were examined 
using immunohistochemistry. By being aware of the specific functions of genes involved 
in regulation of satellite cells, we can begin to understand the development of satellite 
cells within this gene regulatory network and in disease states involving muscle injury.  
Methods 
I. Experimental Mouse Model 
To begin our analysis, we utilized experimental mice lacking Myf5. Conditional 
MyoD alleles were knocked out using the CreLoxP system. To generate the mouse model 
utilized for these experiments, a Cre mouse was bred with a mouse that contained LoxP 
sites around the MyoD allele. The genotypes of the two mice crossed were as follows: 
MyoDiCreER/+Myf5-/- and MyoDcKOMyf5-/+R26NG. The Cre protein was fused with an 
estrogen receptor (ER) and its activity was controlled by tamoxifen, a drug that mimics 
estrogen. After obtaining double-knockout animals with the genotype MyoDiCreER/+Myf5-/-
R26NG/+ we performed various experiments. 
II. Tissue Collection 	
First, tamoxifen was administered at E 11.5. Two milligrams of tamoxifen and 1 
milligram of progesterone, included to minimize negative side effects of tamoxifen, were 
each diluted in corn oil and given to pregnant experimental mice through an IP injection. 
Following tamoxifen injections, the genotype of experimental mice was confirmed using 
polymerase chain reaction (PCR). Subsequently, tissue from experimental mice was 
collected. After dissection, muscle and whole embryo samples were fixed with 
paraformaldehyde, frozen in optimal cutting temperature (OCT) compound and 
cryosectioned at 10 micrometers. The first set of samples was imaged only with DAPI 
staining first. DAPI at a concentration of 0.1 μg/ml was added to slides for 10-15 
minutes. Following imaging with an inverted fluorescence microscope, these slides were 
then stained with anti-GFP antibody to confirm the presence of GFP+ cells. The slides 
were placed in anti-GFP primary antibody overnight, washed 3 times for 5 minutes each 
in PBS, placed in anti-chicken secondary antibody, washed again with PBS as previously 
mentioned, cover-slipped and imaged. All other samples were stained as noted in Table 1. 
III. Immunohistochemistry Staining 
Immunofluorescence staining was performed to identify PAX7+ cells, which 
were thought to be myogenic stem cells. The embryo and tissue samples were also 
stained for CD31, which is a marker of endothelial cells, Perilipin, which labels 
adipocytes, and Myosin Heavy Chain, which identifies a myogenic fate. Table 1 depicts 
the markers we utilized and their corresponding cell lineages. Data from the double-
knockout animals was compared to data from wild-type control mice that contained one 
functional allele of either Myf5 or MyoD. 
Samples that were to be stained for PAX7 were blocked in Mouse-on-Mouse 
(MOM) for two hours to reduce background signal. Similarly, samples that were to be 
stained for CD31 and Myosin Heavy Chain were placed in PBSMT, a blocking solution 
made of 1.5% Bovine Serum Albumin (BSA), 1.5% dry milk, and 0.1% TritonX in PBS 
for two hours. Samples that were to be stained for Osterix and Perilipin were blocked in a 
solution made up of 1.5% BSA, 10% goat serum, and 0.1% TritonX. Primary antibodies 
were diluted in their respective blocking solution, placed onto the samples, and left 
overnight. PAX7 primary antibody was diluted in PBSMT. The next day, samples were 
washed three times in PBS at five minutes per wash. Secondary antibodies were diluted 
in their respective blocking solutions and placed onto samples for 1 to 2 hours. PBS 
washes were repeated as previously stated. DAPI was placed onto samples for 10-15 
minutes at a concentration of 0.1 μg/ml. Lastly, whole tissue samples on slides were 
mounted in Fluorogel, cover-slipped, and imaged using differential interference contrast 
(DIC) microscopy. Brightness of whole images was edited using Photoshop to allow 
better visualization. 
 
 
 
 
 
Lineage Satellite Cell Endothelial Adipogenic Myogenic Osteogenic 
Marker Pax7 CD31 Perilipin Myosin Heavy Chain Osterix 
Primary 
Antibody 
Mouse 
Polyclonal 
Pax7 
Rat-Anti 
Mouse 
CD31 
Sigma 
P1873 MF20 
Rabbit 
Osterix 
Primary 
Antibody 
Dilution 
1:10 1:100 1:500 None 1:250 
Secondary 
Antibody 
Alexa Goat 
Anti-Mouse 
Alexa 
Donkey 
Anti-Rat 
Alexa Goat 
Anti-Rabbit 
Alexa Goat 
Anti-Mouse 
Alexa Fluor 
Anti-Rabbit 
Secondary 
Antibody 
Dilution 
1:250 1:500 1:500 1:500 1:500 
 
IV. FACS Sorting 
The recombined myogenic progenitor cells, which were identified based on GFP 
signal in control and double-knockout animals, were analyzed through fluorescence-
activated cell sorting (FACS) at E 13.5. FACS gating isolated live cells that were GFP+ 
and mononuclear, as indicated by DAPI signal (Figure 12).  
V. Single Cell Plating 
Single GFP+ mononuclear cells were plated into 96 well plates previously coated 
with collagen. Gibco Collagen I was diluted to 50 μg/ml in 20 mM acetic acid and 30 μL 
of the solution was added to each plate. The cells were then grown for 8 days. The 
growth media was made in Dulbecco’s Modified Eagle Medium (DMEM) using 20% 
fetal bovine serum (FBS), 2.5 ng/mL fibroblast growth factor (FGF) and 0.1% 
Penicillin/Streptomycin. The media was changed after 48 hours of initial plating and then 
Table 1. Possible fate changes as determined by immunohistochemistry markers, and 
respective primary and secondary antibodies utilized for the staining protocols. 
every 24 hours until day 8. After 8 days, cells were imaged using DIC microscopy. The 
cells were then placed in differentiation media, made in DMEM using 10% horse serum 
and 1% Penicillin-Streptomycin. After 5 days in differentiation media, the cells were 
subsequently washed, fixed, stained as shown in Table 1 and imaged. Cells from both 
wild type and double knockout mice were plated and treated as described above. We 
followed the same immunohistochemistry staining protocols for both limb tissue samples 
placed on slides and cell culture plates. 
VI. Injury Profile 
To analyze the roles of Myf5 in the absence of MyoD during regeneration, a 
CreER conditional MyoD knockout mouse model was utilized. Tamoxifen was again 
injected into pregnant mice at E 11.5. Seven weeks following the birth of the 
experimental conditional mice, hind limb muscles were injected with cardiotoxin, a snake 
venom that induces apoptosis. Tissue samples were collected 3 days following injury. 
Samples were subsequently dissected, fixed, frozen, and cryosectioned. Lastly, samples 
were analyzed using immunohistochemistry and imaged as described above. 
Results 
 Using the CreLoxP system enabled us to create the necessary mice for our 
experiments, as shown in Figure 4. After crossing MyoDiCreER/+Myf5-/- mice with 
MyoDcKOMyf5-/+R26NG mice, we obtained MyoDiCreER/+Myf5-/-R26NG/+ mice. Tamoxifen 
injections enabled the Cre protein to enter the nucleus and recombine the alleles of 
interest. As a result, GFP signal marked cells that lacked MyoD. However, this method 
does not guarantee perfect recombination frequency at the MyoD locus. Therefore, it is 
possible that some GFP+ cells contained MyoD.  
 	 We began our experiments by sectioning and visualizing control animals 
containing one allele of Myf5. This data is shown in Figure 5. DAPI marks nuclei, which 
enabled us to detect the presence of cells apart from background or debris. The green 
channel depicts GFP signal, while cells that display signal in both the red and green 
channels are auto-fluorescent. Because the fluorescence signal appeared weak and we 
saw significant background interference, we stained the slides with anti-GFP antibody in 
order to amplify the signal of interest (Figure 6). We then compared these data to images 
of double-knockout animals at the same time point (Figure 7). Subsequently, we stained 
	
Figure 4. CreLoxP recombination controlling the expression of MyoD. The Cre 
protein enters the nucleus upon tamoxifen injection and causes recombination, 
rendering MyoD inactive and GFP active. Thus, recombined cells that lack MyoD 
will be marked with GFP. 
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Promoter 
Promoter 
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GFP 
Cre 
MyoD   
Stop Cassette 
Recombined Alleles 
both control and double-knockout tissues collected at E 13.5. Figures 8, 9, 10, and 11 
depict immunofluorescence staining for both CD31, an endothelial marker, and Perilipin, 
an adipogenic marker. We tested our tissue sample for these markers because we believed 
they were the most probable fates the double-knockout population would take. However, 
our data shows no signal for either markers at this time point. Even so, we are not able to 
draw unequivocal conclusions due to the lack of positive control for both Perilipin and 
CD31. Although it may be the case that satellite cell progenitors may have not yet made a 
change towards adipogenic or endothelial fates at E 13.5, it is also possible that staining 
failed to correctly mark adipocytes and endothelial cells or that these cells have not yet 
formed at this time point..  
 
  
Figure 5. Presence of GFP+ cells from 
limbs of Myf5+MyoD- mice at E 13.5. 
Green fluorescence (A) signifies GFP 
signal. DAPI (blue) marks nuclei. Red 
fluorescence (B) and green fluorescence in 
the same location is indicative of auto-
fluorescent tissue. Figure 6C is a merge of 
green (GFP), red (auto-fluorescence) and 
blue (DAPI) fluorescence channels. The 
scale bar represents 50 micrometers.		
 Figure 6. Immunohistochemistry staining 
for GFP from limbs of Myf5+MyoD- mice 
at E 13.5. Green fluorescence (A) 
signifies GFP signal. DAPI (blue) was 
utilized to mark nuclei. Red fluorescence 
(B) and green fluorescence in the same 
location is indicative of auto-fluorescent 
tissue. Figure 7C depicts a merge of 
green (GFP), red (auto-fluorescence) and 
blue (DAPI) fluorescence channels. The 
scale bar represents 50 micrometers. 
 
Figure 7. GFP signal in limbs of double-
knockout mice at E 13.5. Green 
fluorescence (A) signifies GFP signal. 
DAPI (blue) was utilized to mark nuclei. 
Red fluorescence (B) and green 
fluorescence in the same location is 
indicative of auto-fluorescent tissue. 
Figure 8C depicts a merge of green 
(GFP), red (auto-fluorescence) and blue 
(DAPI) fluorescence channels. The scale 
bar represents 50 micrometers. 
 
 Figure 8. Immunohistochemistry staining 
for CD31 in limbs of Myf5+MyoD- mice 
at E 13.5. Green fluorescence (A) 
signifies GFP signal. Red fluorescence 
signifies CD31 signal. DAPI (blue) was 
utilized to mark nuclei. Figure 9C depicts 
a merge of green (GFP), red (CD31) and 
blue (DAPI) fluorescence channels. No 
CD31 signal was identified. The scale 
bar represents 50 micrometers. 
 
Figure 9. Immunohistochemistry staining 
for CD31 in limbs of double-knockout 
mice at E 13.5. Green fluorescence (A) 
signifies GFP signal. Red fluorescence 
signifies CD31 signal. DAPI (blue) was 
utilized to mark nuclei. Figure 10C 
depicts a merge of green (GFP), red 
(CD31) and blue (DAPI) fluorescence 
channels. No CD31 signal was identified. 
 
  
Figure 11. Immunohistochemistry staining 
for Perilipin in limbs of double-knockout 
mice at E 13.5. Green fluorescence (A) 
signifies GFP signal. Red fluorescence 
marks Perilipin. DAPI (blue) marks nuclei. 
Figure 12C depicts a merge of green, red 
and blue fluorescence channels. No 
Perilipin signal was identified at this time 
point. The scale bar represents 50 
micrometers. 	
Figure 10. Immunohistochemistry 
staining for Perilipin in limbs of 
Myf5+MyoD- mice at E 13.5. Green 
fluorescence (A) signifies GFP signal. 
Red fluorescence (B) signifies Perilipin 
signal. DAPI (blue) was utilized to mark 
nuclei. Figure 11C depicts a merge of 
green (GFP), red (Perilipin) and blue 
(DAPI) fluorescence channels. No 
Perilipin signal was identified at this 
time point. 	
Immunofluorescence staining did not show any Perilipin and CD31 signal in 
double-knockout mice at E 13.5, but we were not able to conclude whether or not this 
staining was real. Additionally, we had issues with our sections sliding off of the slides. 
We tried using different time lengths and number of PBS washes during our staining 
protocol, but didn’t seem to obtain significant improvement in the quality of our sections. 
Because we were not able to draw any concrete conclusions from immunofluorescence at 
E 13.5 in tissue, we decided to plate single GFP+ cells and trace their fate changes in 
order to determine if these cells have the capacity to acquire other fates at later time 
points on their own. Single cell plating was utilized to enable the analysis of the capacity 
of each cell to acquire a different fate. Additionally, single cell plating allows further 
RNA sequencing for the assessment of genes expressed. Although we were not able to 
complete this experiment in the interest of time, it is a logical next step. GFP signal was 
identified in the cells by FACS. Although GFP signal is indicative of recombination in 
the CreLoxP construct, recombination does not occur at the MyoD locus in every single 
cell. As such, we believe the majority, but not all, of our GFP+ cells lack MyoD. 
 Figure 12. FACS gating parameters for index-sorted GFP+ cells from 
the limbs of control (A) and double-knockout embryos (B) at E 13.5.	
A 
B 
 After we index-sorted our GFP+ cells by FACS, we placed them in growth media 
for 8 days. Following plating, we checked the cells and were able to visualize GFP 
fluorescence right away.  Although some plates lost GFP signal after a few days, we 
continued to track plates that had previously showed GFP signal under the assumption 
that live cells would remain adhered to the collagen on the plates. In the interest of time, 
we were not able to grow our cells to confluency. Because we did not stain our cells of 
interest until 13 days after plating, we were only able to analyze them through 
morphology and size up until that point. However, these analyses are far more subjective 
than immunofluorescence staining and do not enable us to draw any solid conclusions. 
Figure 13 depicts our findings after 8 days in growth media for wild type (Figure 13A) 
and control (Figure 13B) cells. There were numerous double-knockout plates that showed 
cells with the morphology depicted in Figure 13B. Thus, although we can’t determine the 
fate of these cells based on morphology alone, the appearance of multiple cells with a 
similar morphology in Figure 13B only in the double-knockout plates could be 
significant. 
  
Figure 13. Index-sorted cells from the limbs of MyoD-Myf5+ mice (A) and the limbs 
of double-knockout mice (B) at E 13.5 following eight days in growth media. The 
scale bar represents 20 micrometers. 	
Following 8 days in growth media, we placed our cells in differentiation media 
for 5 days and then stained them for CD31, Perlipin, and Osterix. Although the literature 
and previous lab experiments have shown that fate changes are largely adipocyte or 
endothelial directed, we wanted to ensure that we weren’t missing another fate switch, 
perhaps towards bone. We also stained these cells for PAX7 and Myosin Heavy Chain. 
Although we did not necessarily anticipate a myogenic fate as marked by Myosin Heavy 
Chain, work in our lab has demonstrated that double-knockout satellite cells can express 
PAX7. We identified cells that were positive for CD31, and some that were positive for 
Perilipin (Figures 16 and 17) in our double knockout population. We did not detect any 
cells that were positive for Osterix, which marks differentiated bone, although it is 
certainly possible that satellite cell precursors could take a chondrogenic fate3. We also 
failed to identify any PAX7 and Myosin Heavy Chain signal in our double-knockout 
population (data not shown). Our data from the control population indicated the presence 
of signal that marks cells that are positive for Myosin Heavy Chain and PAX7 (Figures 
14 and 15). However, further studies are needed to accurately determine whether these 
cells have truly acquired a fate change. 
 
 
 
 
 Figure 14. Immunohistochemistry 
staining for PAX7 from GFP+ cells from 
the limb Myf5+MyoD- mice isolated 
through FACS and grown in culture for 
13 days. Figure 14A depicts nuclear 
DAPI signal. Figure 14B depicts PAX7 
signal. Figure 14C depicts a merge of the 
two channels, showing a PAX7+ cell. The 
scale bar represents 50 micrometers. 
 
Figure 15. Immunohistochemistry 
staining for Myosin Heavy Chain from 
GFP+ cells from the limb Myf5+MyoD- 
mice isolated through FACS and grown 
in culture for 13 days. Figure 14A depicts 
nuclear DAPI signal. Figure 14B depicts 
Myosin Heavy Chain signal. Figure 14C 
depicts a merge of the two channels. The 
scale bar represents 50 micrometers. 
 
       
Figure 16. Immunohistochemistry 
staining for Perilipin from GFP+ cells 
from the limbs of double-knockout mice 
isolated through FACS and grown in 
culture for 13 days. Figure 16A depicts 
nuclear DAPI signal. Figure 16B depicts 
Perilipin signal. Figure 16C depicts a 
merge of the two channels with arrows 
pointing towards Perilipin+ cells. The 
scale bar represents 50 micrometers. 
 
Figure 17. Immunohistochemistry 
staining for CD31 from GFP+ cells from 
the limbs of double-knockout- mice 
isolated through FACS and grown in 
culture for 13 days. Figure 17A depicts 
nuclear DAPI signal. Figure 17B depicts 
CD31 signal. Figure 17C depicts a 
merge of the two channels, with an arrow 
pointing towards a CD31+ cell. The 
scale bar represents 50 micrometers. 
 
 To analyze how regeneration occurs in the absence of MyoD, we stained our 
injured experimental animals with Perilipin and CD31, as we believed these would be the 
primary fate changes identified. Our data demonstrates no Perilipin and some CD31 
signal present in muscle fibers three days following injury (Figures 18-21.. Although the 
CD31 signal may be an indication of a potential fate switch, the signal could also arise 
from autofluorescent tissue. Both outcomes are marked by an overlap of green and red 
signal, making it difficult to interpret the data.  
Additionally, there are a significant number of GFP+ fibers in the regenerated 
muscle. As previously mentioned, GFP marks cells that have been recombined through 
the CreLoxP system and thus should lack MyoD. The presence of these fibers in 
regenerated muscle may indicate that regeneration occurred due to the downstream 
effects of Myf5, as MyoD was inactive. This data could show that Myf5 was able to 
compensate for MyoD in regeneration in these experiments. This result is expected, as 
Myf5 has been shown to compensate in the case of MyoD deficiency15. However, it is 
difficult to distinguish GFP+ vasculature in GFP+ fibers. Therefore, a fate switch that’s 
unable to be identified could have also occurred, which would signify that Myf5 alone is 
not able to regenerate muscle.  
  
Figure 18. Immunohistochemistry 
staining for Perilipin from uninjured limb 
muscle of Myf5+MyoD- mice. Figure 18A 
depicts GFP signal in the green channel, 
Figure 18B depicts a lack of Perilipin 
signal in the red channel. Figure 18C is a 
merge of green (GFP), red (Perilipin) 
and blue (DAPI) signals. There is no 
Perilipin signal in this experimental 
mouse. The scale bar represents 20 
micrometers. 
 
Figure 19. Immunohistochemistry 
staining for Perilipin from injured limb 
muscle of Myf5+MyoD- mice three days 
post injury. Figure 19A depicts GFP 
signal in the green channel, Figure 19B 
depicts a lack of Perilipin signal in the 
red channel. Figure 19C is a merge of 
green (GFP), red (Perilipin) and blue 
(DAPI) signals. There is no Perilipin 
signal in this experimental mouse. 
 
 Figure 20. Immunohistochemistry 
staining for CD31 from uninjured limb 
muscle of Myf5+MyoD- mice. Figure 20A 
depicts GFP signal in the green channel, 
Figure 20B depicts CD31 signal in the 
red channel. Figure 20C is a merge of 
green (GFP), red (CD31) and blue 
(DAPI) signals. The arrows in the merge 
point to normal vasculature as marked by 
CD31. The scale bar represents 20 
micrometers. 
 
Figure 21. Immunohistochemistry 
staining for CD31 from injured limb 
muscle of Myf5+MyoD- mice three days 
following injury. Figure 20A depicts GFP 
signal in the green channel, Figure 20B 
depicts CD31 signal in the red channel. 
Figure 20C is a merge of green (GFP), 
red (CD31) and blue (DAPI) signals. The 
scale bar represents 20 micrometers. 
 
Discussion 
 In sum, our data showed that when MyoD is knocked out of Myf5 negative 
experimental mice at E 11.5, satellite cell progenitors do not display any signal indicating 
a change towards adipogenic or endothelial lineages at E 13.5. This could mean that the 
time point is too early for a complete fate change to occur in the limbs of experimental 
mice. However, this data is also equivocal in the lack of positive controls for the 
immunofluorescence stains, as well as other staining showing the exact location of the 
GFP+ cells in the limbs. Coming to a significant conclusion is difficult without further 
experiments. 
When isolated and grown in culture for 8 days, these cells appear to show signal 
that may indicate a fate change The primary issue that we had with these cells was loss of 
GFP signal. Although after a few days in culture our cells no longer appeared GFP+, we 
believed that a significant quantity of the cells in the plates were MyoD knockouts. We 
first identified GFP signal in the embryo limbs upon dissection using fluorescence 
microscopy. Additionally, the FACS gating was specific for index-sorted live GFP+ 
mononuclear cells. Lastly, we assumed that these cells remained alive, in spite of a lack 
of GFP signal, because they did not lift up from the bottom of the plate. As such, we 
continued our analysis. 
In our control population, we did not observe signal indicating fate changes 
towards an endothelial, chondrogenic, or adipogenic lineage. Rather, we saw primarily 
Myosin Heavy Chain+ cells following 8 days in growth media and 5 days in 
differentiation media, as in Figure 15. As single Myf5+ animals have been shown to have 
the ability to carry out complete myogenic programming, we expected to observe a 
myogenic fate lineage. We were able to observe Myosin Heavy Chain positive and some 
PAX7+ cells. The Myosin Heavy Chain is an indicator of differentiated muscle. PAX7 is 
expressed in quiescent satellite cells, before Myf5 and MyoD, as shown in Figure 1. This 
indicates that the PAX7+  cells may be myogenic stem cells that have remained 
undifferentiated. 
Although both samples contain GFP+ cells, there could be a fate change in the 
double-knockout embryos, while the control animals are shown to display signal that 
marks myogenic programming. After 8 days in growth media and 5 days in 
differentiation media, double-knockout satellite cell progenitors can be identified by a 
few different immunohistochemistry markers that indicate different cell lineages. The 
majority of these cells displayed signal that marks an endothelial or adipogenic fate. 
Because either Myf5 or MyoD is required for proper differentiation to a myogenic fate,16 
we expected that Myf5 and MyoD double knockout cells would not develop to form 
functional muscle or muscle progenitors. Instead, we expected to observe a fate switch. 
Because previous work in the Goldhamer lab has shown that this fate switch will be most 
likely towards adipose tissue, we expected to see an increase in Perilipin signal in the 
double-knockout mice when compared to wild-type mice. We believed the majority of 
satellite cell progenitors would show an adipogenic fate switch. 
Although we stained our double-knockout population for osteogenic and 
myogenic markers, signal from markers indicating these fate changes couldn’t be 
identified (data not shown). However, differentiation of cartilage and muscle is regulated 
by some common factors, such as Sox9 and Pax33. Therefore, it is possible that 
chondrogenic cells were present in our population, but had not yet formed bone. In this 
way, staining for Sox9 at this time point may have been more suitable. Additionally, we 
weren’t able to detect the presence of PAX7+ cells either. This was true for both time 
points (8 days in growth media, 8 days in growth media followed by 5 days in 
differentiation media) in our single-cell plating culture experiments. 
A fate change towards endothelial cells was also potentially expected. Pax family 
genes regulate both endothelial and myogenic cell lineages. During limb bud formation, 
this signal causes some myogenic progenitors to take an endothelial fate. Therefore, we 
anticipated seeing a potential increase in CD31 signal in double-knockout animals. 
However, we were surprised to observe a significant number of cells displaying markers 
for an endothelial fate, as opposed to an adipogenic fate. We expected to observe mostly 
adipose tissue signal, as adipose is usually the most prevalent lineage that satellite cell 
precursors take. However, it is possible that in the absence of MyoD and Myf5, Pax genes 
act to promote an endothelial cell lineage.  
Lastly, we believed the possibility of myogenic progenitors or a myogenic fate to 
be unlikely, but possible. The other two myogenic regulatory factors, Myogenin and 
MRF4, should not have the ability to compensate for loss of MyoD and Myf5 in myogenic 
differentiation. However, MyoD will have been active for only a short amount of time 
and it is possible that the gene may have contributed to the determination of a myogenic 
fate in this time. Another reason why we may have observed myogenic cells or myogenic 
precursors is due to recombination efficiency. Recombination in every cell at the MyoD 
locus is not guaranteed. As such, the occurrence of GFP+ cells that contain a MyoD allele 
is possible.  
We did not necessarily anticipate observing a fate switch in our Myf5 single-allele 
MyoD-knockout mice upon injury. Because MyoD is first expressed at E 11.5, knocking 
the gene out at that time point would allow it to be active during a short time in 
development, but not in regeneration due to injury Additionally, as previously mentioned, 
MyoD and Myf5 have redundant roles in myogenesis. Thus, we anticipated that injury and 
loss of muscle could lead to regeneration due to the downstream effects of Myf5 up 
regulation.   
 Our injury profile data showed that that our Myf5+/MyoD- experimental mice do 
not depict signal indicating a fate change towards an adipogenic lineage (Figure 19). As 
in our double-knockout E 13.5 population, we observed signal indicating a potential fate 
switch towards an endothelial cell lineage, as marked by CD31 (Figure 21). Again, this 
could be due to the ability of Pax genes to regulate both myogenic and endothelial cells. 
However, endothelial and myogenic cells are closely associated, as previously 
mentioned. Thus, it could also be possible that the CD31 signal shown was due to normal 
vasculature. CD31 signal in GFP+ cells may indicate the presence of an endothelial fate 
switch. Additionally, it is also possible that this is autofluorescent tissue. Consequently, 
without further experiments, whether these cells did take an endothelial fate remains 
unknown. 
As previously stated, we saw a significant number of GFP+ fibers in the 
regenerated muscle. GFP signal indicates that these fibers have been recombined and 
should lack MyoD. Due to imperfect recombination, it is not accurate to assume that each 
one of these recombined cells is MyoD-/-. However, because a significant number of the 
regenerated fibers are GFP+, we can assume that the majority of these fibers lack MyoD 
and regeneration occurred due to the effects of Myf5. Interestingly enough, this intense 
GFP signal is appears to be depicted only in the regenerated fibers that were stained for 
CD31. This signal is not as fluorescent in the regenerated muscle that was stained for 
Perilipin. This occurrence could be explained by a lack of recombined fibers in the area 
imaged or due to an error in imaging.  
In sum, we were unable to detect Perilipin signal in our injury profile data, as 
demonstrated in Figure 19. Although we identified CD31 signal, it is difficult to say with 
certainty that these cells are present due to a fate switch from myogenic precursors. Myf5 
and MyoD are both known to have the ability to carry out myogenic programming 
individually and they are both activated during satellite cell proliferation following 
injury, leading to regeneration of muscle fibers2  
Although creating an injury profile for double-knockout animals would align 
better with the first component of my thesis, this experiment is unable to be completed 
due to embryonic fatality. Double-knockout animals have a low rate of survival for a full-
term birth. This number decreases for mice that reach adulthood and would be 
exacerbated by cardiotoxin injection, rendering this experiment virtually impossible. 
Next Steps 
 
As previously mentioned, the single-cell plating in our experiment was initially 
done to further RNA sequencing analysis. Though we were not able to complete this step 
due to time constraints, this would be the next step in our research. In order to further 
support the possible conclusions that can be taken away from our data, we could also take 
bright field images showing the morphology of our cells of interest. For example, the 
detection of a lipid droplet in the cells that we believe may have taken a fate switch 
towards an adipogenic lineage would confirm data from Perilipin staining. Additionally, 
the images in Figures 6-11 were taken from embryonic limbs. Imaging these sections 
using a light microscope or performing a hematoxylin stain would enable us to view the 
morphology and location of GFP+ cells within the limbs. Lastly, a positive control (i.e. 
staining adipocytes from our embryos for Perilipin) in the context of our experimental 
setting is necessary to confirm the accuracy of our results.  
To further explore the roles of Myf5 and MyoD in myogenesis, various 
experimental options could be performed. For example, our single-cell plating 
experiments could be repeated at different time points, such as E 15.5 and E 17.5. These 
are both time points in fetal myogenesis. At E 15.5, the basal lamina, located adjacent to 
satellite cells, is beginning to form. Similarly, the formation of satellite cells is still 
occurring at E 17.5. Completing these experiments would enable us to determine whether 
fate change occurs primarily during the embryonic stage or the fetal stage. Likewise, we 
could repeat FACS analysis. However, instead of single-cell plating, we could index sort 
GFP+ cells in populations to observe possible fate changes in this capacity. We initially 
plated single cells to evaluate the ability of each cell to acquire a fate change. Plating 
cells in populations may in turn allow us to see how neighboring cells influence fate 
changes and whether or not all cells in an adjacent location take the same fate. 
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